13F-HR filed by CHARLES SCHWAB INVESTMENT MANAGEMENT INC
CHARLES SCHWAB INVESTMENT MANAGEMENT INC filed this 13F-HR for the quarter ended 2024-09-30, filed 2024-11-12, with 3,501 holding rows worth $523,952,370,188.
- Accession
- 0001752724-24-247180
- Filer
- CIK 884546
- Filed
- 2024-11-12
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q3 2024
A combination report, 3,639 entries on the cover page, a total value of $523,952,370,188 stated on the cover page (in dollars after the unit check, H1), rows summing to $523,952,370,188 with VALUE read as dollars as filed, 13F file number 028-03128. The quarter's positions are built on this report. The resolved quarter.
Other managers
- reports for this filerAMERICAN CENTURY COMPANIES INC028-11918
- reports for this filerJPMORGAN CHASE & CO028-00694
- reports for this filerARIEL INVESTMENTS, LLC028-04003
- reports for this filerCOLUMBIA MANAGEMENT INVESTMENT ADVISERS, LLC028-10477
- reports for this filerHARRIS ASSOCIATES L P028-02013
- reports for this filerBAILLIE GIFFORD OVERSEAS LTD028-04395
- included managerCharles Schwab Trust Co028-19636
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| CONDUIT PHARMACEUTICALS INC | 20678X106 | COM | 53,111 | $6,294 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001752724-24-247180 | this filing | 2024-11-12 | acceptance time not in the bulk data set |